Loading...

Caris Life Sciences, Inc.

CAINASDAQ
Healthcare
Biotechnology
$29.54
$0.05(0.17%)

Caris Life Sciences, Inc. (CAI) Stock Overview

Explore Caris Life Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.5/100

Key Financials

Market Cap8.2B
P/E Ratio19.08
EPS (TTM)$-2.57
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$31.24

CAI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Caris Life Sciences, Inc. (CAI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $31.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.08 and a market capitalization of 8.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;